Home・Lista de Ações・Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corp

Fechado

SetorSaúde

17.05 -3.51

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

16.98

Máximo

17.6

Indicadores-chave
By Trading Economics
Rendimento	9.2M 4.6M
Vendas	27M 419M
EPS	0.56
Margem de lucro	1.103
Funcionários	4,427
EBITDA	-35M 28M

Recomendações
By TipRanks
Recomendações	Neutro
Previsão para 12 meses	+9.11% upside

Dividendos
By Acuity
Próximos Ganhos	29 de out. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-129M 1.4B
Abertura anterior	20.56
Fecho anterior	17.05

Sentimento de Notícias

By Acuity

25%

75%

72 / 340 Ranking em Healthcare

Integra LifeSciences Holdings Corp Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

6 de ago. de 2026, 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Wednesday's close. The stock remains below its 20-day moving average.

5 de ago. de 2026, 19:36 UTC

Integra Lifesciences Holdings Corp shares are lower today, continuing a decline since Tuesday's close. The stock remains significantly below its 20-day moving average.

4 de ago. de 2026, 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Tuesday's session, approximately 3.60% below the 20-day moving average, with no specific news identified.

3 de ago. de 2026, 20:51 UTC

Integra Lifesciences Holdings Corp gains in after-market hours, reflecting broader market optimism despite no specific company news. Major indices also show significant increases.

31 de jul. de 2026, 19:46 UTC

Integra Lifesciences Holdings Corp shares are lower during Friday's session, trading near the lower end of their one-month range with no specific news identified.

30 de jul. de 2026, 17:41 UTC

Integra Lifesciences Holdings Corp shares are higher today, despite earlier session pullbacks. No specific news was identified to explain the movement.

29 de jul. de 2026, 21:01 UTC

Integra Lifesciences shares are lower in after-market hours, reflecting a broader decline in U.S. equities amid rising oil prices and geopolitical tensions.

28 de jul. de 2026, 20:03 UTC

News

Shares of Integra Lifesciences Holdings are higher, supported by UBS's Neutral rating and price target of $19 amid broader Health Care Equipment gains.

27 de jul. de 2026, 19:51 UTC

Integra Lifesciences Holdings Corp shares are lower today amid notable volatility, despite remaining near the upper end of their one-month trading range.

24 de jul. de 2026, 19:02 UTC

News

Integra Lifesciences shares are higher today, following a downgrade from Wall Street Zen and a price target increase from Truist Financial to $19.00.

21 de jul. de 2026, 18:46 UTC

Integra Lifesciences Holdings shares are higher amid broader market recovery, despite a slight pullback from earlier gains. The stock remains above its 20-day moving average.

20 de jul. de 2026, 19:26 UTC

News

Integra Lifesciences Holdings is lower amid broader market pressure from rising Treasury yields. Investors await upcoming quarterly results after exceeding earnings expectations.

Comparação entre Pares

Variação de preço

Integra LifeSciences Holdings Corp Previsão

Preço-alvo

By TipRanks

9.11% parte superior

Previsão para 12 meses

Média 19.29 USD 9.11%

Máximo 25 USD

Mínimo 17 USD

Com base em 9 analistas de Wall Street que oferecem metas de preço de 12 meses para Integra LifeSciences Holdings Corp - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Neutro

9 ratings

Comprar

Manter

Vender

Com base em 9 analistas que deram avaliações de ações para Integra LifeSciences Holdings Corp - Dist nos últimos 3 meses.

Sentimento

By Acuity

72 / 340 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Integra LifeSciences Holdings Corp

Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical products, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as after-market services. It also sells instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute wounds; and surgical tissue repair products for hernia, tendon, peripheral nerve repair and protection. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.